REVENUES (Tables)
|
6 Months Ended |
Jun. 30, 2023 |
REVENUES |
|
Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands): | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2023 | | 2022 | | 2023 | | 2022 | Product sales: | | | | | | | | | | | | | Gross product sales | | $ | 33,456 | | $ | 26,427 | | $ | 66,654 | | | 49,045 | Discounts and allowances | | | (9,575) | | | (7,877) | | | (19,028) | | | (14,298) | Total product sales, net | | | 23,881 | | | 18,550 | | | 47,626 | | | 34,747 | Revenues from collaborations: | | | | | | | | | | | | | License revenues | | | — | | | 2,337 | | | — | | | 2,545 | Development milestones | | | — | | | 5,000 | | | — | | | 5,000 | Royalty, delivery of drug supplies and others | | | 2,005 | | | 3,932 | | | 4,330 | | | 4,262 | Total revenues from collaborations | | | 2,005 | | | 11,269 | | | 4,330 | | | 11,807 | Government contract | | | 1,000 | | | — | | | 1,000 | | | — | Total revenues | | $ | 26,886 | | $ | 29,819 | | $ | 52,956 | | $ | 46,554 |
|
Schedule of product revenue allowance and reserve categories |
| | | | | | | | | | | | | | | Chargebacks, | | Government | | | | | | | Discounts and | | and Other | | | | | | | Fees | | Rebates | | Returns | | Total | Balance as of January 1, 2023 | | $ | 6,213 | | $ | 2,636 | | $ | 3,296 | | $ | 12,145 | Provision related to current period sales | | | 14,439 | | | 3,725 | | | 395 | | | 18,559 | Credit or payments made during the period | | | (13,139) | | | (3,765) | | | (116) | | | (17,020) | Balance as of June 30, 2023 | | $ | 7,513 | | $ | 2,596 | | $ | 3,575 | | $ | 13,684 |
| | | | | | | | | | | | | | | Chargebacks, | | Government | | | | | | | | | Discounts and | | and Other | | | | | | | | | Fees | | Rebates | | Returns | | Total | Balance as of January 1, 2022 | | $ | 3,404 | | $ | 2,494 | | $ | 2,017 | | $ | 7,915 | Provision related to current period sales | | | 9,680 | | | 2,711 | | | 613 | | | 13,004 | Credit or payments made during the period | | | (7,748) | | | (2,901) | | | (39) | | | (10,688) | Balance as of June 30, 2022 | | $ | 5,336 | | $ | 2,304 | | $ | 2,591 | | $ | 10,231 |
|
Schedule of revenues from product sales disaggregated by customers |
The following table summarizes the percentages of revenues from each of our customers who individually accounted for 10% or more of the total net product sales and revenues from collaborations: | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | 2023 | | 2022 | | | 2023 | | 2022 | McKesson Specialty Care Distribution Corporation | | | 44% | | | 34% | | | | 45% | | | 36% | Cardinal Healthcare | | | 28% | | | 16% | | | | 26% | | | 20% | ASD Healthcare and Oncology Supply | | | 19% | | | 12% | | | | 21% | | | 19% | Kissei | | | — | | | 25% | | | | — | | | 16% |
|